Why should quality metrics be used for infectious disease assessment, management and follow up in solid organ transplantation?

Página do item simplificado
dc.creatorWanessa Trindade Clemente
dc.creatorJordi Carratalà
dc.date.accessioned2023-07-03T23:33:49Z
dc.date.accessioned2025-09-08T23:06:47Z
dc.date.available2023-07-03T23:33:49Z
dc.date.issued2020-09-18
dc.format.mimetypepdf
dc.identifier.doi10.1016/j.cmi.2020.08.039
dc.identifier.issn1198743X
dc.identifier.urihttps://hdl.handle.net/1843/55718
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofClinical Microbiology and Infection
dc.rightsAcesso Aberto
dc.subjectIndicadores de Qualidade em Assistência à Saúde
dc.subjectTransplante de orgãos
dc.subject.otherHealthcare-associated infections
dc.subject.otherQuality metrics
dc.subject.otherSolid Transplant infections
dc.subject.otherTransplant safety
dc.titleWhy should quality metrics be used for infectious disease assessment, management and follow up in solid organ transplantation?
dc.typeArtigo de periódico
local.citation.epage15
local.citation.spage12
local.citation.volume9
local.description.resumoThis article presents our viewpoint based on our combined experience in transplantation, transplant infectious disease complications and health-care-associated infection (HAI) tracking systems. Quality metrics for transplant infectious disease should allow us to track donor safety, perform vaccinations, control prophylaxis adherence rates, and monitor the rates of surgical-site infections (SSIs) and other infections. However, even with targeted screening using highly sensitive pre-transplantation tests, adequate vaccination and prophylaxis, there may be some gaps in the process that can impact the outcomes. Transplant programmes should pay close attention to and document prophylaxis failures, HAI rates, rehospitalizations and excessive immunosuppression. With this in mind, we chose 16 indicators that we believe would demonstrate the quality of the transplant programme in each phase of the process, which may impact the infection risk.
local.identifier.orcidhttps://orcid.org/0000-0003-0848-3740
local.publisher.countryBrasil
local.publisher.departmentMED - DEPARTAMENTO DE PROPEDÊUTICA COMPLEMENTAR
local.publisher.initialsUFMG
local.url.externahttps://www.sciencedirect.com/science/article/pii/S1198743X2030522X?via%3Dihub

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
Why should quality metrics used for infectious disease assesment pdfa.pdf
Tamanho:
133.75 KB
Formato:
Adobe Portable Document Format
Baixar

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
License.txt
Tamanho:
1.99 KB
Formato:
Plain Text
Descrição:
Baixar

Coleções

Artigo de Periódico

Logo UFMG